The Rise in Robotic Atypical Segmentectomies
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Electronic Health Record Review.
- Who it may be relevant to
- Registry conditions: Lung Carcinoma. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Rise in Robotic Atypical Segmentectomies: A Large Cancer Center Experience
Overview
This study investigates the increased rate of robotic atypical segmentectomies. Segmentectomy refers to removing a section of a lobe of the lung. Reviewing patients' data retrospectively may help researchers determine whether robotic surgery has led to an increase in atypical segmentectomy.
Detailed description
PRIMARY OBJECTIVES:
I. To evaluate the rate of increase in robotic segmentectomies performed at our institution per year.
II. To evaluate the rate of typical and atypical segmentectomies performed at our institution per year.
III. To characterize the differences in robotic versus other types of resections such as open and VATS (video-assisted thoracic surgery).
OUTLINE:
Patients' medical records are reviewed retrospectively.
Interventions
- Other Electronic Health Record Review
Review of medical records
Primary outcome measures
- Rate of change in robotic segmentectomies [Time frame: Up to 2 years]
- Rate of typical and atypical segmentectomies [Time frame: Up to 2 years]
- Differences in robotic versus other types of resections such as open and video-assisted thoracic surgery [Time frame: Up to 2 years]
Eligibility criteria
Inclusion criteria
- Patients who underwent a lung resection from 2004 to 2019
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Case-only
Study locations
United States · 1 center
- M D Anderson Cancer Center — Houston
Identifiers
NCT: NCT04644952 · 2020-0696 · NCI-2020-10080 · 2020-0696